Skip to main content
Log in

Gallic Acid Protects 6-OHDA Induced Neurotoxicity by Attenuating Oxidative Stress in Human Dopaminergic Cell Line

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Gallic acid is one of the most important polyphenolic compounds, which is considered an excellent free radical scavenger. 6-Hydroxydopamine (6-OHDA) is a neurotoxin, which has been implicated in mainly Parkinson’s disease (PD). In this study, we investigated the molecular mechanism of the neuroprotective effects of gallic acid on 6-OHDA induced apoptosis in human dopaminergic cells, SH-SY5Y. Our results showed that 6-OHDA induced cytotoxicity in SH-SY5Y cells was suppressed by pre-treatment with gallic acid. The percentage of live cells (90%) was high in the pre-treatment of gallic acid when compared with 6-OHDA alone treated cell line. Moreover, gallic acid was very effective in attenuating the disruption of mitochondrial membrane potential, elevated levels of intracellular ROS and apoptotic cell death induced by 6-OHDA. Gallic acid also lowered the ratio of the pro-apoptotic Bax protein and the anti-apoptotic Bcl-2 protein in SH-SY5Y cells. 6-OHDA exposure was up-regulated caspase-3 and Keap-1 and, down-regulated Nrf2, BDNF and p-CREB, which were sufficiently reverted by gallic acid pre-treatment. These findings indicate that gallic acid is able to protect the neuronal cells against 6-OHDA induced injury and proved that gallic acid might potentially serve as an agent for prevention of several human neurodegenerative diseases caused by oxidative stress and apoptosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Abbreviations

6-OHDA:

6-Hydroxydopamine

PD:

Parkinson’s disease

ROS:

Reactive oxygen species

SOD:

Superoxide dismutase

CAT:

Catalase

GPx:

Glutathione peroxidase

LDH:

Lactate dehydrogenase

GA:

Gallic acid

DCDFA:

2′,7′-Dichlorofluorescein diacetate

DMEM:

Dulbecco’s modified Eagle’s medium

ΔΨm:

Mitochondrial membrane potential

References

  1. de Lau LM, Breteler MM (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5:525–535

    Article  PubMed  Google Scholar 

  2. Shulman JM, De Jager PL, Feany MB (2011) Parkinson’s disease: genetics and pathogenesis. Annu Rev Pathol 6:193–222

    Article  PubMed  CAS  Google Scholar 

  3. Mullin S, Schapira AHV (2015) Pathogenic mechanisms of neurogeneration in Parkinson disease. Neurol Clin 33:1–17

    Article  PubMed  Google Scholar 

  4. Hu Y, Tong Y (2010) A Trojan horse for Parkinson’s disease. Sci Signal 3:p13–pe13

    Article  CAS  Google Scholar 

  5. Chong SJF, Low ICC, Pervaiz S (2014) Mitochondrial ROS and involvement of Bcl-2 as a mitochondrial ROS regulator. Mitochondrion 19:39–48

    Article  PubMed  CAS  Google Scholar 

  6. Navya K, Kumar GP, Anilakumar KR (2017) Ameliorating effect of Curculigo orchoides on chromium(VI) induced oxidative stress via, modulation of cytokines, transcription factors and apoptotic genes. J Appl Biomed 15:299–306

    Article  Google Scholar 

  7. Jiang XW, Bai JP, Zhang Q, Hu XL, Tian X, Zhu J, Liu J, Meng WH, Zhao QC (2017) Caffeoylquinic acid derivatives protect SH-SY5Y neuroblastoma cells from hydrogen peroxide-induced injury through modulating oxidative status. Cell Mol Neurobiol 37:499–509

    Article  PubMed  CAS  Google Scholar 

  8. Kumar GP, Anilakumar KR, Naveen S (2015) Phytochemicals having neuroprotective properties from dietary sources and medicinal herbs. Pharmacogn J 7:1–17

    Article  Google Scholar 

  9. Mazo NA, Echeverria V, Cabezas R, Avila-Rodriguez M, Aliev G, Leszek J, Barreto GE (2017) Medicinal plants as protective strategies against Parkinson’s disease. Curr Pharm Des 23:4180–4188

    Article  PubMed  CAS  Google Scholar 

  10. Yoon CH, Chung SJ, Lee SW, Park YB, Lee SK, Park MC (2013) Gallic acid, a natural polyphenolic acid, induces apoptosis and inhibits proinflammatory gene expressions in rheumatoid arthritis fibroblast-like synoviocytes. Joint Bone Spine 80:179–274

    Article  CAS  Google Scholar 

  11. Umadevi S, Gopi V, Simna S, Parthasarathy A, Yousuf SMJ, Elangova V (2012) Studies on the cardio protective role of gallic acid against age-induced cell proliferation and oxidative stress in H9C2 (2–1) cells. Cardiovasc Toxicol 12:304–311

    Article  PubMed  CAS  Google Scholar 

  12. Rasool MK, Sabina EP, Ramya SR, Preety P, Patel S, Mandal N, Mishra PP, Samuel J (2010) Hepatoprotective and antioxidant effects of gallic acid in paracetamol-induced liver damage in mice. J Pharm Pharmcol 62:638–643

    Article  CAS  Google Scholar 

  13. Dhingra D, Chhillar R, Gupta A (2012) Antianxiety-like activity of gallic acid in unstressed and stressed mice: possible involvement of nitriergic system. Neurochem Res 37:487–494

    Article  PubMed  CAS  Google Scholar 

  14. Tieu K (2011) A guide to neurotoxic animal models of Parkinson’s disease. Csh Perspect Med 1:a009316

    Google Scholar 

  15. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63

    Article  PubMed  CAS  Google Scholar 

  16. Ramya EM, Kumar GP, Anand T, Anilakumar KR (2017) Modulatory effects of Terminalia arjuna against domoic acid induced toxicity in Caco-2 cell line. Cytotechnology 69:725–739

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  17. LeBel CP, Ischiropoulos H, Bondy SC (1992) Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5:227–231

    Article  PubMed  CAS  Google Scholar 

  18. Liu Y, Zeng X, Hui Y, Zhu C, Wu J, Taylor DH, Ji J, Fan W, Huang Z, Hu J (2015) Activation of α7 nicotinic acetylcholine receptors protects astrocytes against oxidative stress-induced apoptosis: implications for Parkinson’s disease. Neuropharmacology 91:87–96

    Article  PubMed  CAS  Google Scholar 

  19. Sunkaria A, Yadav A, Sharma SK, Sandhir R (2017) Molecular mechanisms involved in the neuroprotective action of phytochemicals. Neuroprot Eff Phytochem Neurol Disord 515–559

  20. Sekhar YC, Kumar GP, Anilakumar KR (2017) Terminalia arjuna bark extract attenuates picrotoxin-induced behavioral changes by activation of serotonergic, dopaminergic, GAB Aergic and antioxidant systems. Chin J Nat Medicines 15:584–596

    Article  Google Scholar 

  21. Workman DG, Tsatsanis A, Lewis FW, Boyle JP, Mousadoust M, Hettiarachchi NT, Hunter M, Peers CS, Tétard D, Duce JA (2015) Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson’s with novel 1-hydroxypyridin-2-one metal chelators. Metallomics 7:867–876

    Article  PubMed  CAS  Google Scholar 

  22. Izumi Y, Sawada H, Sakka N, Yamamoto N, Kume T, Katsuki H, Shimohama S, Akaike A (2005) p-quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly. J Neurosci Res 79:849–860

    Article  PubMed  CAS  Google Scholar 

  23. Xie L, Hu LF, Teo XQ, Tiong CX, Tazzari V, Sparatore A, Del Soldato P, Dawe GS, Bian JS (2013) Therapeutic effect of hydrogen sulfide-releasing L-Dopa derivative ACS84 on 6-OHDA-induced Parkinson’s disease rat model. PLoS ONE 8:e60200

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Naoi M, Inaba-Hasegawa K, Shamoto-Nagai M, Maruyama W (2017) Neurotrophic function of phytochemicals for neuroprotection in aging and neurodegenerative disorders: modulation of intracellular signalling and gene expression. J Neural Transm 124:1515–1527

    Article  PubMed  CAS  Google Scholar 

  25. Nie G, Cao Y, Zhao B (2002) Protective effects of green tea polyphenols and their major component, (–)-epigallocatechin-3-gallate (EGCG), on 6-hydroxydopamine-induced apoptosis in PC12 cells. Redox Rep 7:171–177

    Article  PubMed  CAS  Google Scholar 

  26. Cohen JJ, Duke RC, Fadok VA, Sellins KS (1992) Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10:267–293

    Article  PubMed  CAS  Google Scholar 

  27. Tortosa A, Lopez E, Ferrer I (1997) Bcl-2 and Bax proteins in Lewy bodies from patients with Parkinson’s disease and diffuse Lewy body disease. Neurosci Lett 238:78–80

    Article  PubMed  CAS  Google Scholar 

  28. Vander Heiden MG, Thompson CB (1999) Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1:E209

    Article  PubMed  CAS  Google Scholar 

  29. Hwang DS, Kim HG, Kwon HJ, Cho JH, Lee CH, Lee JM, Jang JB, Kim YS, Lee KS, Oh MS (2011) Dangguijakyak-san, a medicinal herbal formula, protects dopaminergic neurons from 6-hydroxydopamine-induced neurotoxicity. J Ethnopharmacol 133:934–939

    Article  PubMed  Google Scholar 

  30. Zhang Z, Hou L, Li X, Ju C, Zhang J, Li X, Wang X, Liu C, Lv Y, Wang Y (2016) Neuroprotection of inositol hexaphosphate and changes of mitochondrion mediated apoptotic pathway and α-synuclein aggregation in 6-OHDA induced parkinson׳ s disease cell model. Brain Res 1633:87–95

    Article  PubMed  CAS  Google Scholar 

  31. Wu CR, Tsai CW, Chang SW, Lin CY, Huang LC (2015) Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson’s disease: involvement of antioxidative enzymes induction. Chem-Biol Interact 225:40–46

    Article  PubMed  CAS  Google Scholar 

  32. Miller DM, Singh IN, Wang JA, Hall ED (2013) Administration of the Nrf2–ARE activators sulforaphane and carnosic acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial dysfunction ex vivo. Free Radical Bio Med 57:1–9

    Article  CAS  Google Scholar 

  33. Dinkova-Kostova AT, Abramov AY (2015) The emerging role of Nrf2 in mitochondrial function. Free Radical Bio Med 88:179–188

    Article  CAS  Google Scholar 

  34. Wang H, Wang Y, Zhao L, Cui Q, Wang Y, Du G (2016) Pinocembrin attenuates MPP+-induced neurotoxicity by the induction of heme oxygenase-1 through ERK1/2 pathway. Neurosci Lett 612:104–109

    Article  PubMed  CAS  Google Scholar 

  35. Wang H, Liu X, Long M, Huang Y, Zhang L, Zhang R, Zheng Y, Liao X, Wang Y, Liao Q, Li W (2016) NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis. Sci Transl Med 8:334ra51

    Article  PubMed  CAS  Google Scholar 

  36. Qi G, Mi Y, Wang Y, Li R, Huang S, Li X, Liu X (2017) Neuroprotective action of tea polyphenols on oxidative stress-induced apoptosis through the activation of the TrkB/CREB/BDNF pathway and Keap1/Nrf2 signaling pathway in SH-SY5Y cells and mice brain. Food Funct 8:4421–4432

    Article  PubMed  CAS  Google Scholar 

  37. Chao J, Lau WK, Huie MJ, Ho YS, Yu MS, Lai CS, Wang M, Yuen WH, Lam WH, Chan TH, Chang RC (2010) A pro-drug of the green tea polyphenol (–)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine. Neurosci Lett 469:360–364

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank Director, DFRL (DRDO) for his valuable suggestions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Phani Kumar.

Ethics declarations

Conflict of interest

The authors declare that there are no conflicts of interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chandrasekhar, Y., Phani Kumar, G., Ramya, E.M. et al. Gallic Acid Protects 6-OHDA Induced Neurotoxicity by Attenuating Oxidative Stress in Human Dopaminergic Cell Line. Neurochem Res 43, 1150–1160 (2018). https://doi.org/10.1007/s11064-018-2530-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-018-2530-y

Keywords

Navigation